Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT01775618
Eligibility Criteria:
Inclusion Criteria:
* Males \< 12 years of age
* Subjects with severe hemophilia A
* Previously treated with FVIII for \> 50 exposure days
Exclusion Criteria:
* Subjects with current evidence of or history of inhibitors to FVIII
* Any other inherited or acquired bleeding disorder
* Platelet counts \< 100,000/mm\^3
* Creatinine \> 2x the upper limit of normal
* Aspartate aminotransferase (AST) / Alanine aminotransferase (ALT) \> 5x the upper limit of normal
Healthy Volunteers:
False
Sex:
MALE
Maximum Age:
12 Years
Study:
NCT01775618
Study Brief:
Protocol Section:
NCT01775618